Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Diabetes Technology & Therapeutics|June 14, 2014
Diabetes and the Affordable Care ActMark R Burge, David S Schade
Diabetes Technology & Therapeutics|September 2, 2016
The Role of a Coronary Artery Calcium Scan in Type 1 DiabetesMark R Burge, R Philip Eaton, David S Schade
Metabolism: Clinical and Experimental|May 31, 2002
The mechanism of glucose-induced catecholamine stimulationAmer G Rassam, Patrick Martin, Mark R Burge, et al.
Diabetes Technology & Therapeutics|November 27, 2002
Frequency of the dawn phenomenon in type 2 diabetes: implications for diabetes therapyMary F Carroll, Kevin J Hardy, Mark R Burge, et al.
Diabetes Care|November 28, 2002
Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagoguesMary F Carroll, Ahmad Izard, Katrina Riboni, et al.
Journal of the Endocrine Society|December 22, 2017
Management of Asymptomatic Patients With Positive Coronary Artery Calcium ScansMark R Burge, R Philip Eaton, George Comerci, et al.
Diabetes Technology & Therapeutics|April 25, 2014
Is the masked continuous glucose monitoring system clinically useful for predicting hemoglobin A1C in type 1 diabetes?Elizabeth Duran-Valdez, Mark R Burge, Paula Broderick, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 4, 2017
INSULIN TIMING: A PATIENT-CENTERED APPROACH TO IMPROVE CONTROL IN TYPE 1 DIABETESElizabeth Duran-Valdez, Mark R Burge, Paula Broderick, et al.
Diabetes Technology & Therapeutics|September 27, 2003
Diabetes mellitus associated with atypical anti-psychotic medicationsClifford Clark, Mark R Burge
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 8, 2004
Insulin edema in the twenty-first century: review of the existing literatureAruna Chelliah, Mark R Burge
Pageof 8